Overexpression of the IGF2-mRNA binding protein p62 in transgenic mice induces a steatotic phenotype.

Elisabeth Tybl, Fu-Dong Shi, Sonja M Kessler, Sascha Tierling, Jörn Walter, Rainer M Bohle, Stefan Wieland, Jianying Zhang, Eng M Tan, Alexandra K Kiemer

Saarland University, Department of Pharmacy, Pharmaceutical Biology, Saarbrücken, Germany.

Journal of hepatology 2011 May

filter terms:

The insulin-like growth-factor 2 (IGF2) mRNA binding protein p62 is highly expressed in hepatocellular carcinoma tissue. Still, its potential role in liver disease is largely unknown. In this study, we investigated pathophysiological implications of p62 overexpression in mice. We generated mice overexpressing p62 under a LAP-promotor. mRNA expression levels and stability were examined by real-time RT-PCR. Allele-specific expression of Igf2 and H19 was assessed after crossing mice with SD7 animals. The Igf2 downstream mediators pAKT and PTEN were determined by Western blot. Hepatic p62 overexpression neither induced inflammatory processes nor liver damage. However, 2.5week old transgenic animals displayed a steatotic phenotype and improved glucose tolerance. p62 overexpression induced the expression of the imprinted genes Igf2 and H19 and their transcriptional regulator Aire (autoimmune regulator). Neither monoallelic expression nor mRNA stability of Igf2 and H19 was affected. Investigating Igf2 downstream signalling pathways showed increased AKT activation and attenuated PTEN expression. The induction of a steatotic phenotype implies that p62 plays a role in hepatic pathophysiology. Copyright © 2010 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Citation

Elisabeth Tybl, Fu-Dong Shi, Sonja M Kessler, Sascha Tierling, Jörn Walter, Rainer M Bohle, Stefan Wieland, Jianying Zhang, Eng M Tan, Alexandra K Kiemer. Overexpression of the IGF2-mRNA binding protein p62 in transgenic mice induces a steatotic phenotype. Journal of hepatology. 2011 May;54(5):994-1001